Glenmark Pharmaceuticals receives affirmation in LT issuer credit ratings

Image
Capital Market
Last Updated : Nov 25 2020 | 9:50 AM IST

From S&P Global Ratings

Glenmark Pharmaceuticals announced that S&P Global Ratings has affirmed the long-term issuer credit rating on Glenmark and the issue rating on the company's US$200 million senior unsecured notes at 'BB-'. At the same time, the credit rating agency has removed all the ratings from CreditWatch with negative implications. The outlook has been changed to Stable.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 25 2020 | 9:36 AM IST

Next Story